Insider Trading March 25, 2026

Kaltura Finance EVP Adds 10,000 Shares at $1.29; Company Posts Large EPS Beat in Q4 2025

Claire Rotshten buys $12,900 of stock as Kaltura reports stronger-than-expected earnings while trading near its 52-week low

By Hana Yamamoto KLTR
Kaltura Finance EVP Adds 10,000 Shares at $1.29; Company Posts Large EPS Beat in Q4 2025
KLTR

Claire Rotshten, Kaltura Inc.'s Executive Vice President of Finance, purchased 10,000 shares on March 23, 2026, at $1.29 per share. The transaction coincides with a recent quarterly earnings beat and a stock trading near its 52-week low. Analysts have forecast profitability for FY2026 at $0.03 per share.

Key Points

  • Kaltura EVP of Finance Claire Rotshten purchased 10,000 shares on March 23, 2026, at $1.29 per share for $12,900.
  • Rotshten was previously granted 105,263 restricted stock units on January 19, 2026; RSUs vest quarterly over four years beginning April 1, 2026.
  • Kaltura reported Q4 2025 EPS of $0.03 versus expected $0.0006 and revenue of $45.5 million versus $45.32 million forecast.

Claire Rotshten, Executive Vice President of Finance at Kaltura Inc. (NASDAQ: KLTR), made an open-market purchase of 10,000 common shares at $1.29 per share, a transaction that totaled $12,900. The acquisition was reported on a Form 4 filed with the Securities and Exchange Commission and is dated March 23, 2026.

The insider buy occurred while Kaltura's shares were trading at approximately $1.25, a price level that reflects a roughly 26% decline over the prior six months. The stock is also trading close to its 52-week low of $1.06.


Additional details from the SEC filing show that Rotshten previously acquired 105,263 shares on January 19, 2026. Those shares were issued in the form of restricted stock units, each representing a contingent right to receive one share of common stock. The RSUs are scheduled to vest in quarterly installments over a four-year period, with vesting beginning on April 1, 2026.

After the March 23 transaction, Rotshten's direct holdings in Kaltura total 1,039,973 shares.


On the corporate reporting front, Kaltura posted fourth-quarter 2025 results that exceeded analyst expectations on the bottom line. The company reported earnings per share of $0.03, topping the anticipated $0.0006 per share - a variance described in the filing as a 4900% surprise. Revenue for the quarter was $45.5 million, modestly ahead of the forecasted $45.32 million.

The combination of a notable EPS surprise and only a slight revenue beat has been a focal point for market participants. The earnings release and the timing of the insider purchase provide discrete data points for investors assessing management alignment and near-term financial momentum.


Analyst expectations for the fiscal year 2026 indicate a forecasted earnings per share of $0.03, implying that some market observers anticipate the company will be profitable this year. The article does not provide additional analyst rating changes or other corporate developments such as mergers or acquisitions, and it notes that no new analyst upgrades or downgrades were reported in the most recent updates.

Given the factual record available - the March 23 Form 4 purchase, the January 19 RSU grant, the RSU vesting schedule beginning April 1, 2026, the reported Q4 2025 results, and the current trading range relative to the 52-week low - investors have concrete, disclosed items to incorporate into their own analysis. The article does not draw conclusions beyond these reported facts.

Risks

  • Shares are trading near a 52-week low of $1.06 and have declined roughly 26% over six months - market volatility and downside risk in the equity markets could continue to affect holders. (Equities, technology/software sector)
  • The insider purchase is limited in size relative to total holdings and does not, by itself, alter company fundamentals or guarantee future stock appreciation - investors should weigh disclosed transactions alongside financial results. (Equities, investor sentiment)
  • No recent mergers, acquisitions, or analyst rating changes were reported, meaning new catalysts may be limited in the near term absent additional company announcements. (Capital markets, corporate activity)

More from Insider Trading

Hyperfine COO Sells Shares to Cover RSU Taxes After Strong 2025 Results Mar 25, 2026 10x Genomics CEO Disposes $288,908 in Stock Through Prearranged Plan Mar 25, 2026 22NW Fund, LP Disposes of 106,919 L.B. Foster Shares in Three-Day Selling Run Mar 25, 2026 Prosperity Bancshares Director Sells 1,100 Shares for $72,867; Company Posts Mixed Q4 2025 Results Mar 25, 2026 Royalty Pharma CFO Disposes of $1.58 Million in Class A Shares; Company Announces Financing and Leadership Hires Mar 25, 2026